The Ras oncogene is known to activate three major MAPK pathways, ERK, JNK, p38 and exert distinct cellular phenotypes, that is, apoptosis and invasion through the Ras-MKK3-p38-signaling cascade. We attempted to identify the molecular targets of this pathway that selectively govern the invasive phenotype. 
The Ras oncogene is known to activate three major MAPK pathways, ERK, JNK, p38 and exert distinct cellular phenotypes, that is, apoptosis and invasion through the Ras-MKK3-p38-signaling cascade. We attempted to identify the molecular targets of this pathway that selectively govern the invasive phenotype. Stable transfection of NIH3T3 fibroblasts with MKK3 act cDNA construct revealed similar p38-dependent in vitro characteristics observed in Ha-Ras EJ -transformed NIH3T3 cells, including enhanced invasiveness and anchorage-independent growth correlating with p38 phosphorylation status. To identify the consensus downstream targets of the Ras-MKK3-p38 cascade involved in invasion, in vitro invasion assays were used to isolate highly invasive cells from both, MKK3 and Ha-Ras EJ transgenic cell lines. Subsequently a genome-wide transcriptome analysis was employed to investigate differentially regulated genes in invasive Ha-Ras EJ -and MKK3 act -transfected NIH3T3 fibroblasts. Using this phenotype-assisted approach combined with system level protein-interaction network analysis, we identified FOXM1, PLK1 and CDK1 to be differentially regulated in invasive Ha-Ras EJ -NIH3T3 and MKK3 act -NIH3T3 cells. Finally, a FOXM1 RNAknockdown approach revealed its requirement for both invasion and anchorage-independent growth of Ha-Ras
Introduction
Signal transduction pathways enable cells to react to a variety of external as well as internal stimuli (Schwacke and Voit, 2007) . Perturbation of certain signaling modules by, for example, mutations or aberrant growth factor signaling can induce an unfavorable outcome for the organism, such as tumorigenesis and tumor progression (Ozanne et al., 2007) . However, many cellular systems are protected by mechanisms that fine-tune the signal transduction pathways by triggering apoptosis in response to aberrant activation of oncogenic pathways and this is felt to be the consequence of an activation of phenotype-specific downstream regulators (Sun et al., 2007) . The identification of such regulators is of great interest not only due academic but also from due to a therapeutic reason.
The Ras-MKK3/6-p38 signal transduction pathway is a perfect example. It confers cellular migration and invasion, but at the same time apoptosis (Haq et al., 2002; Deng et al., 2004; Behren et al., 2005; Qi et al., 2006; Sun et al., 2007) . In this study we attempted to identify downstream regulators of this pathway that specifically convey signals culminating in an in vitro invasive phenotype.
Ras is a well-studied oncogene and a central regulator of a diverse set of biological functions, including cell proliferation, morphology, cellular migration and invasion, but also cellular senescence and growth arrest (Moon, 2006) . Oncogenic Ras activates multiple signal transduction pathways, which either consist of stressor mitogen-activated protein kinases (SAPKs and MAPKs), including the p38, JNK/SAPK and p42/p44 MAPK/ERK pathways (Marshall, 1996) . In general, growth factors and tumor promoters stimulate extracellular signal-regulated kinases (ERKs), while JNKs and p38 isoforms are activated by environmental stress such as UV light, osmotic stress but also inflammatory cytokines (Denhardt, 1996) . Both, MAPKs and SAPKs are regulated by upstream kinases (Raman et al., 2007) and consist of a three module system transducing the signal through subsequent phosphorylation into the nucleus. Two kinases, MKK3 and MKK6, are known to activate p38 (Raingeaud et al., 1996; Schaeffer and Weber, 1999) .
All of the three known Ras proteins (Ha-Ras, Ki-Ras and N-Ras) can induce malignant transformation in mammalian cells, if certain point mutations occur (Stacey and Kung, 1984; Downward, 2003) . These mutations are detected in about 20-30% of all human cancers. One common mutation in the Ha-Ras gene is the EJ mutation, which consists of substitution of valine for glycine in codon 12. Cells carrying this mutation colonize the lungs of athymic nude mice after tail vein injection (Bradley et al., 1986; Zhang and Schultz, 1992) . Moreover, it has been demonstrated that both ERK1/2 and JNK are active in Ha-Ras EJ stably transfected NIH3T3 cells, but only ERK was required for an invasive phenotype (Janulis et al., 1999) . We have previously demonstrated that p38 is also required for in vitro invasion of v-Ha-Ras EJ stably transfected NIH3T3 cells (Behren et al., 2005) .
In contrast, Ras-MKK3/6-p38 activation is also known to trigger apoptosis, cellular senescence and growth (Sun et al., 2007) . Anticancer approaches aiming to inhibit the p38 pathway at the SAPK or higher levels are not feasible due to the fact that both apoptosis and tumor growth/invasion are under the control of the same pathway. Therefore, identification of downstream components of the Ras-MKK3/6-p38 signal transduction pathway that selectively regulate cellular migration/ invasion while not affecting cellular apoptosis and senescence, would be of highest therapeutic interest.
Here we introduced a phenotype-assisted, genomewide expression profiling strategy to systematically identify key regulatory components downstream of the activated Ras-MKK3-p38-signaling pathway that govern cellular migration and invasion process. Our results provide novel and compelling evidence that FOXM1, a forkhead/winged-helix transcription factor that is specifically upregulated in a broad variety of cancers, that is, colon, prostate, pancreas and lung cancers (Pilarsky et al., 2004; Kalin et al., 2006; Yoshida et al., 2007) , functions downstream of this cascade and is required for regulation of invasion and anchorage-independent growth. It is tempting to speculate that FOXM1 serves as one of the major relay stations for the induction of invasion by signals through the Ras-p38 pathway and that cellular phenotype decisions may in part depend on FOXM1.
Results

Stable transfection of NIH3T3 fibroblasts with an MKK3
act cDNA construct revealed similar in vitro invasive characteristics as compared with Ha-Ras EJ -transformed NIH3T3 cells Considering that Ha-Ras confers invasion through MKK3 and p38 (Shin et al., 2005) , we hypothesized that in vitro invasion may be triggered by constitutive activation of MKK3 alone. (Figures 1a and b ). ATF2 is a typical downstream target of p38 (Song et al., 2006) and incubation of ATF2 with protein lysates of the maternal and both transformed cell lines in the presence of ATP led to phosphorylation of ATF2 demonstrating constitutive activation of p38 in HaRas and MKK3 act NIH3T3 cells (Figure 1d ). The pooled MKK3 act clone consisting of B50 clones derived from propagation in G418 selection medium shows nearly 100% enhanced invasiveness in in vitro invasion chambers as compared with maternal NIH3T3 cells (10.5%±4 versus 5.5%±3%). Moreover, it almost reaches the invasiveness of Ha-Ras EJ -transformed NIH3T3 cells (17% ± 6%) ( Figure 1c ). The data suggest that both Ha-Ras and MKK3 induce in vitro invasion in NIH3T3 cells that correlates with the p38 phosphorylation and activity status. Finally, four separately picked and propagated clones were further characterized with respect to in vitro invasion. This revealed only minor differences of the level of in vitro invasion in three out of four clones (21 versus 19 versus 27%), suggesting a relatively high level of homogeneity with respect to the invasive phenotype within the pooled MKK3 act clone (Figure 1e ). One clone, however, showed an in vitro invasion capacity similar to the untransfected NIH3T3 cell line, demonstrating heterogeneity within different transfectants from one cell line, due to either different insertion sites of the expression plasmid or differences in the epigenetic and transcriptional background of the individual cell.
MKK3-induced invasion requires activation of p38 and is not dependent on JNK nor can it be inhibited by the MEK1 inhibitor PD098059 In order to identify genes involved in in vitro invasion regulated by a single pathway, the Ras-MKK3-p38 pathway, it is important to investigate whether MKK3 executes the invasive phenotype solely through p38. The involvement of other MAPKs activated by MKK3 is not unlikely considering a cross-talk between the p38, ERK and JNK pathways (Schwacke and Voit, 2007) . Moreover, constitutive activation of MKK3 may confer an abnormally strong and sustained signal and thus may activate other MAPK pathways (Qi et al., 2006) .
As a consequence we investigated the phosphorylation of other MAPKs, including JNK and ERK. While there was only minimal phosphorylation of JNK, we found moderate activation of ERK (Figure 2a) . In order to rule out the possibility that MKK3 triggered invasion signals through the MEK-ERK pathway, we incubated MKK3 act -NIH3T3 cells with PD098059, an inhibitor of MEK1, and SB203580. While SB203580, a specific FOXM1 is a downstream target of Ras-MKK3-p38
A Behren et al inhibitor of p38, significantly reduces in vitro invasion of MKK3 act cells, this was not the case using PD098059 (Figures 2b and d) . Moreover, increasing concentrations of PD098059 (5, 10, 25 mM) also failed to have an effect on in vitro invasion of pooled MKK3 act cells (Supplementary data), while 10 mM PD098059 nearly completely abolished the phosphorylation of ERK1 and ERK2, and its downstream target ELK (Figure 2c ). This suggests that moderate activation of the MEK-ERK pathway does not contribute to the in vitro invasive phenotype brought about by MKK3 act .
Phenotype-assisted genetic expression profiling identifies novel signaling components downstream from Ras-MKK3-p38 that are required for in vitro invasion Given that Ha-Ras and MKK3 may regulate a slightly different spectrum of genes, we aimed to systematically identify a consensus set of genes that confers cellular in vitro invasion by both activated Ha-Ras and MKK3 signaling. Thus, we adopted a two-step approach: (A) we subjected both the Ha-Ras EJ and MKK3 act clones to in vitro invasion assays and isolated invasive cells and (B) we compared differentially expressed genes based on Figure 1 p38 activation is paralleled by an increase in the infiltrative capacity. NIH3T3 cells were transiently transfected with the indicated constructs. Forty-eight hours later protein lysates were generated and used for western blotting (a), as well as lysates from the NIH3T3pool and the untransfected NIH3T3 cell line (b). The commercially available NIH and NIHras cell lines and the generated MKK3pool line were examined in matrigel-based invasion assays. Invasion is shown as percentage of cells invading through the matrigel and the porous membrane as compared with the overall number of cells. The bars show means±s.d. Statistical analyses were performed using Student's t-test; *Pp0.05; ***Pp0.005 (c). Antibodies for either whole p38 expression or just p-p38 expression were applied. Lysate from heat-shocked NIH3T3 served as a positive control. Protein lysates of the indicated cell lines were normalized for protein amount and immunoprecipitation was performed for the detection of pATF. Lysates were separated by SDS-polyacrylamide gel electrophoresis with subsequent western blotting for the detection of the outlined proteins. Actin served as a control for equal loading (d). Four stable MKK3 act -transfected individual clones, termed C1-C4, were examined for their invasion capacity as described previously using matrigel-based invasion assays (e).
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A Behren et al genome-wide expression profiling from invasive cells of both clones in order to identify a consensus set of genes only differentially regulated in in vitro invasive cells by Ha-RasEJ and MKK3 act . Total RNA isolated from noninvasive, wild-type NIH3T3 cells was used as reference to compare (a) induction of genes by constitutive activation of MKK3 and Ha-Ras and (b) the consensus set of genes differentially regulated by both pathways that confers cell invasion.
Using this two-step approach we identified 777 transcripts differentially regulated in invasive versus non-invasive Ha-Ras EJ and MKK3 act NIH3T3 cells (Po0.01 after t-test, 1000 permutations and standard Bonferroni correction). This set of genes is presented as a heat map ( Figure 3 ) and the gene-tables are available in Supplementary data. Hierarchical clustering using Dot product distances and complete linkage analysis confirmed that the two different MKK3 act transgenic cell populations demonstrated similar expression pattern. Invasive Ha-Ras and MKK3 cells clustered together, while non-invasive transgenic cells built the second major branch after hierarchical clustering.
Next, we set out to identify potential direct interactions among the upregulated genes in the invasive population. We found that a substantial fraction of the consensus Ha-Ras/MKK3-induced 'invasive gene Figure 2 The increased invasive potential of the MKK3pool cells can be countered by a p38 but not an ERK inhibitor. Cell lysates from NIH and MKK3pool cells were equalized for protein amount and analyzed for the presence of JNK, ERK and their active, phosphorylated forms. An antibody directed against b-actin served as control (a). Invasion assays were performed to examine the influence of an ERK inhibitor (PD098059) on the infiltrative potential of NIH and MKK3pool cells. The inhibitor was added to the upper and the lower compartment of the Boyden chamber at a concentration of 10 mM (b). After treatment of cells with 10 mM PD098059 the same cells were harvested and lysates were used for SDS-polyacrylamide gel electrophoresis to show inhibition of activated ERK and its downstream target ELK. The blots were performed as described under Materials and methods (c). An invasion assay was performed using SB203580, an inhibitor for the SAPK p38 at 10 mM (d). All experiments were performed at least in triplicate. The bars show mean ± s.d. Statistic analyses were performed using Student's t-test; ***Pp0.005. ERK, extracellular signal-regulated kinase.
A Behren et al signature' directly interacts and constitutes a generegulatory network. Network analysis reveals a critical involvement of several 'hub' nodes (red circles), including FOXM1, PLK1 and CDK1 (Figure 4 ). The identified hub node FOXM1 was subject of a more detailed investigation.
FOXM1 expression is upregulated in Ha-Ras and MKK3
act -NIH3T3 cells through activation of p38 One of the most interesting genes differentially expressed in both invasive Ha-Ras and MKK3
act -NIH3T3 cells is FOXM1. This gene encodes a forkhead/wingedhelix transcription factor that regulates malignant growth and invasion (Wierstra and Alves, 2007) . However, it does not induce apoptosis (Kalinina et al., 2003; Gusarova et al., 2007; Park et al., 2009 ) and thus may specifically confer the Ras-MKK3-p38-dependent invasive phenotype. FOXM1 is highly expressed in MKK3 act -and Ha-Ras EJ -transformed NIH3T3 cells. Examining invasive and non-invasive cells isolated through in vitro invasion assay demonstrates, moreover, much higher levels of expression of this gene in the invasive cell population as shown by semi-quantitative endpoint as well as qPCR (Figures 5a and b) . Using the p38 inhibitor SB203580 we could show that FOXM1 expression depends on the activity of p38 in both Ha-Ras EJ -and MKK3 act -transformed cells by the same methods (Figures 5c and d) . A 10-mM concentration of SB203580 was sufficient to decrease the FoxM1 RNA level more than four-fold in the MKK3pool cell line, while a 2fold reduction could be observed in NIHras cells. In order to more firmly establish that FOXM1 is a downstream target of the Ha-Ras-MKK3-p38 pathway we performed reporter assays employing the full-length FOXM1 promoter (Korver et al., 1997) transiently transfected into Ha-RasEJ-and MKK3 act -transformed cells. Our results indicate a strong transactivation of the promoter (Figure 5e ) that was more pronounced in ras-transformed cells and could be abolished by incubating ras-and MKK3 act -transformed cells with the p38 inhibitor SB203580 (Figure 5f ).Thus, FOXM1 should be considered downstream of the Ha-Ras-MKK3-p38 cascade.
FOXM1 expression and p38 activation is required for in vitro invasion and anchorage-independent growth in Ha-Ras EJ and MKK3 act NIH3T3 cells Upregulation of FOXM1 expression particularly in the invasive cell population in Ha-Ras and MKK3 act NIH3T3 cells suggests a role of this protein in the regulation of Ras-MKK3-p38-dependent in vitro invasion. In order to examine this question, we used an RNA-interference approach. Downregulation of FOXM1 with small interfering RNA (siRNA) is shown by semi-quantitative and qPCR (Figures 6a and b) . In addition, cotransfection of both NIHras and MKK3pool cells with FoxM1-specific siRNA along with a FoxM1 expression construct results in restoration of FoxM1 RNA levels as compared to that in untransfected cells, demonstrating the functionality of the FOXM1 siRNA (Figure 6b) .
The downregulation of FoxM1 RNA by siRNA resulted in a reduction of in vitro invasion in both NIHras and MKK3pool cells (50 ± 5%, 50 ± 3%) as determined in a matrigel-based invasion assay (Figure 6c) . In order to exclude the possibility of Figure 3 Phenotype-assisted gene expression analysis. NIH3T3 cell were engineered to constitutively overexpress MKK3 and HaRas (Ras). Cells were selected based on their phenotypic presentation, that is, invasive versus non-invasive population of Ha-Ras EJ and MKK3 act transgenic NIH3T3 cells. Genome-wide transcriptional analysis revealed a consensus set of 777 transcripts to be differentially regulated in invasive versus non-invasive cells after MKK3 or Ras activation (Po0.01). The selected set of consensus genes is presented as a heat map using hierarchical clustering, with Dot product distances and complete linkage analysis. Each row represents log 2 expression ratios of an individual gene (Ha-Ras EJ or MKK3 act versus maternal wild-type NIH3T3) and the columns indicate non-invasive and invasive MKK3 act (two different clones) and Ha-Ras EJ (one clone) NIH3T3 transgenic cells. Expression ratios are colored according to the scale bar.
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A Behren et al off-target effects on other RNAs brought about by the FOXM1 siRNA as the reason for this change in phenotype, we performed a rescue experiment where we cotransfected siRNA along with a FoxM1 expression vector into NIHras and MKK3pool cells. This experiment revealed a rescue of in vitro invasion back to the levels of untransfected NIHras and MKK3pool cells. Overall these experiments suggest that FOXM1 expression is required for in vitro invasion of both NIHras and MKK3pool cells (Figure 6c ).
Anchorage-independent growth is one hallmark of the malignant phenotype and typically reported from Ha-Ras EJ transformation of NIH3T3 cells (Moon, 2006) . Thus we investigated the role of FOXM1 in the regulation of anchorage-independent growth in HaRas EJ -and MKK3 act -transformed NIH3T3 cells. We found that both Ha-Ras and MKK3 act induce anchorage-independent growth in soft agar as well as in bacterial petri dishes not treated for cell culture (Figure 7a ). This effect can be abrogated by SB203580, an inhibitor of the two p38 isoforms alpa and beta (Kumar et al., 1997) , and an RNA interference against FOXM1 (Figure 7b ). This suggests that this Ha-Ras-MKK3-p38-dependent phenotype requires FOXM1 expression to be executed. Of note, no change to proliferation on regular culture plates was noted (data not shown).
Discussion
Here we report the identification of the forkhead/ winged-helix transcription factor FOXM1 as a novel downstream target of the Ras-MKK3-p38-signaling pathway in a phenotype-assisted, genome-wide transcriptome analysis. We show that expression of FOXM1 is required for Ha-Ras-MKK3-p38-induced cellular in vitro invasion and anchorage-independent cell growth, two hallmarks of cancer development and progression.
FOXM1 is a forkhead/winged-helix transcription factor that is specifically upregulated in a broad variety of cancers, that is, colon, prostate, pancreas and lung cancers (Pilarsky et al., 2004; Kalin et al., 2006; Yoshida et al., 2007) . Moreover, this transcription factor appears to play a major role in early tumorigenesis of head and neck squamous cell cancers (Gemenetzidis et al., 2009) and seems not to induce apoptosis (Kalinina et al., 2003; Gusarova et al., 2007; Park et al., 2009) . It displays a proliferation-specific expression pattern. Typical activators of expression are PMA, c-AMP, tumor necrosis factor-a (TNF-a) and lipopolysaccharide (LPS). MEK1/2 and UV irradiation have been shown to increase phosphorylation and transactivation capacity. Transforming growth factor-b1 was shown to inhibit FOXM1 expression (Wierstra and Alves, 2007) . act and Ha-Ras EJ NIH3T3 cells. An Ha-Ras-and MKK3-induced gene-regulatory network that confers cell invasion. We found that more than 80 genes upregulated by both MKK3 and HaRas and phenotypically selected for governing NIH3T3 cell invasion directly interact in a comprehensive gene-regulatory network. The regulation of the identified 'hub nodes' (genes in red circle) were confirmed by real-time quantitative reverse transcription-PCR. The hub node FOXM1 was subject of more detailed functional analysis.
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As a prerequisite for this study it was critical to develop a stable cell line expressing a constitutively activated MKK3 mutant. The effect of activation of MKK3 is quite variable. Several studies report that MKK3 plays a significant role in the regulation of apoptosis (Ichijo et al., 1997) . In contrast to these data, MKK3 has also been demonstrated to play a role in cellular survival. This effect is brought about by Rac1, a RAS-superfamily GTPase. Rac1-dependent activation of MKK3 results in induction of the serine/threonine kinase Mirk/Dyrk1B that promotes cellular survival (Jin et al., 2005) .
Finally the Ras-MKK3/6-p38 pathway plays a role in the regulation of cellular invasion. This has been demonstrated using breast epithelial cells and NIH3T3 cells (Shin et al., 2005) . Also, the role of MKK3 has lately been highlighted for glioma invasion (Demuth et al., 2007) .
Our data suggest that stable transfection of NIH3T3 cells with MKK3 act results in an in vitro invasive phenotype. Moreover, the MKK3 act -dependent phenotype is quite comparable to the Ha-Ras-induced phenotype. Although we found a lesser degree of in vitro invasion, MKK3 also induced anchorage-independent growth in a p38-dependent manner as demonstrated for Ha-Ras-transformed NIH3T3 cells using the specific p38 inhibitor SB203580. Of note, we found MKK3 expression to be induced in Ha-Ras-transformed NIH3T3 cells, suggesting this to be a critical event toward the development of a malignant phenotype brought about by Ha-Ras. Our data support the findings of other investigators, that activation of the MKK3/6-p38 pathway is sufficient to induce in vitro invasion (Reunanen et al., 2002; Shin et al., 2005; Song et al., 2006; Junttila et al., 2007) . Our findings exceed current knowledge in that we show that activation of this pathway is also sufficient to induce anchorageindependent growth, a hallmark of the malignant phenotype.
It is interesting that we found moderate activation of ERK1/2 demonstrated by phosphorylation of this kinase in the MKK3 act cells. PD098059, an MEK1 
A Behren et al inhibitor, fails to inhibit in vitro invasion in MKK3 act cells, but abolishes the phosphorylation of ERK1/2 and ELK. This suggests that activation of MEK1/2 and ERK1/2 is of no relevance to the invasive phenotype triggered by MKK3. The Ras-MKK3-p38 pathway has been widely studied and found to regulate a plethora of cellular phenotypes as different and opposing as cellular senescence and invasion. As a consequence there is a great deal of interest focused on the downstream regulators that are responsible for the execution of these phenotypes. This interest is not only of academic origin but also of therapeutic interest, since targeting signal transduction pathways that regulate various phenotypes is threatened with significant and unpredictable side effects. In this study we have been able to observe FOXM1 to act downstream from RAS-MKK3-p38 and confer invasion and anchorageindependent growth signals. Recently published data demonstrate furthermore, that upregulation of FOXM1 prevents apoptosis and senescence (Park et al., 2009) and may even be downregulated upon induction of dormancy through p38 (Adam et al., 2009 ). Thus, FOXM1 may serve as a therapeutic target to eliminate those effects of the p38 pathway that support the malignant phenotype, without affecting possible induc- Figure 6 siRNA-mediated knockdown of FoxM1leads to downregulation of p38-dependent invasion, which can be restored by overexpression of FoxM1. siRNA against FoxM1 was transfected with Oligofectamine in the outlined cell lines. Forty-eight hours later RNA extraction and reverse transcription were performed. 18S RNA shows equal loading, NIH3T3 RNA was used as negative control. The gel pictures were inverted for a better visualization; the separated lanes indicate that the neighboring probes were not run next to each other (a). siRNA against FoxM1 was transfected with Oligofectamine (Invitrogen) in the outlined cell lines. To restore the FoxM1 transcript levels (rescue experiment) cells were cotransfected with siRNA against FoxM1 plus a FoxM1 expression plasmid in a 1:2 ratio. Forty-eight hours later RNA extraction and reverse transcription were performed. The transcript levels of FoxM1 and 18SRNA were analyzed by RQ-PCR (b). NIHras and MKK3pool cells were plated out in DMEM supplemented with 10% fetal calf serum. The following day cells were transfected with siRNA directed against FoxM1 and also cotransfected with a FoxM1 expression plasmid (Origene). The following day cells were trypsinized and 80 000 cells were seeded in the Boyden chambers. The number of cells infiltrating the matrigel layer and the membrane is expressed as percentage of the untransfected cell lines, which were set to 100% (c). The bars show the mean±s.d. Statistical analyses were performed with Student's t-test; **Pp0.01; ***Pp0.005. DMEM, Dulbecco's modified Eagle's medium; siRNA, small interfering RNA.
A Behren et al tion of senescence and/or apoptosis that would be of therapeutic benefit. In order to the identify downstream targets of the Ras-MKK3-p38 pathway that are involved in the regulation of invasion, we used an unsupervised genetic expression profiling approach in combination with in vitro phenotyping. Genetic expression profiling is nowadays available to many biomedical laboratories. Through addition of a simple in vitro invasion assay we were able to identify a subset of genes involved particularly in in vitro invasion. Combination of gene subsets from both Ha-Ras-and MKK3-transformed cells allowed the identification of genes downstream from the entire Ha-Ras-MKK3-p38 cascade. We believe that this approach that we call phenotypeassisted, genome-wide transcriptome analysis may prove to be of value in the future for identification of genes downstream from various signal transduction pathways and involved in the regulation of specific phenotypes.
Materials and methods
Cell lines and lysates
All cell lines were grown in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum. NIH3T3 and NIH3T3 cells expressing mutated ras were purchased from CLS (Cell-Lines-Service, Heidelberg, Germany). MKK3b(E)-expressing NIH3T3 cells were constructed by transfection of NIH3T3 cells with linearized vector DNA and subsequent treatment with growth media (DMEM supplemented with 10% fetal calf serum) containing 750 mg/ml G418. Following 2 weeks of treatment with selection media, the surviving cell colonies (B50) were either picked separately yielding MKK3 C1-C4 or harvested, pooled and termed MKK3pool. These cell lines were continuously grown in selection media up to passage 15. For cell lysates, cells were lysed at 80% confluence using cell lysis buffer (CST) supplemented with phenylmethylsulfonyl fluoride. Samples were normalized for protein amount after BCA assay and used for immunoprecipitation or separated by SDS-polyacrylamide gel electrophoresis. Downregulation of FoxM1 as well as blockade of p38 activity abrogates anchorage-independent growth. NIH3T3, NIHras and MKK3pool cells were seeded in bacterial petri dishes and the medium was changed after 10 h of incubation at 37 1C under 5% CO 2 . Twenty hours later pictures were taken. Cells plated out in 0.35% top agar over a layer of 0.7% bottom agar were grown for 4 weeks under standard conditions. The colonies so formed were stained with MTT for 5 h and plates were scanned (a). All experiments were performed in triplicate and pictures are representative. NIHras cells were plated out in parallel with MKK3pool cells in bacterial petri dishes and transfected with either siRNA directed against FoxM1 or control siRNA, or treated with 10 mM SB203580 or an equivalent amount of DMSO. Pictures were taken 2 days after the indicated treatment (b). DMSO, dimethylsulfoxide; siRNA, small interfering RNA.
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Western blotting and immunoprecipitation
After transferring proteins to a polyvinylidene difluoride membrane, the membranes were blocked in 4% bovine serum albumin/TBST or 4% skimmed milk overnight. Primary antibodies were used at the following dilutions: p38, 1:3000; p-p38 and p-ATF antibody, 1:1000; JNK, 1:3000; pJNK, 1:1000; ERK, 1:2000 and p-ERK, 1:1000 (all CST); anti-actin, 1:3000 and anti-MKK3 1:3000 (all from Santa Cruz Biotechnology, Santa Cruz, CA, USA). Primary antibody incubation was performed at 4 1C overnight in 5% bovine serum albumin/ TBST except for ERK, JNK and MKK3, which were used in 5% non-fat dry milk in PBST. Secondary antibodies were used at 1:4000 for 1 h at room temperature. ECL plus (GE Healthcare, Chalfont St Giles, UK) based chemiluminescence detection was performed after secondary antibody incubation. p-ATF and p-ELK were detected after immunoprecipitation overnight and subsequent kinase assay according to the manufactures protocol (CST).
Transient transfection NIH3T3 cells were transfected with 1 mg of the indicated constructs and 4 ml Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) per well of a 12-well plate. The constitutively active MKK3-expressing construct has been described elsewhere (Han et al., 1996; Jiang et al., 1996) and mock control was prepared using the empty vector (pcDNA3). For reporter-gene assays 1 mg of empty vector or reporter-gene vector encoding the FoxM1 promoter in front of the luciferase gene (Korver et al., 1997; Laoukili et al., 2005) were transfected into the respective cell lines or cotransfected with the constitutively active MKK3 expression construct using the JetPrime reagent (PeqLab, Erlangen, Germany) at a 1:1 ratio. siRNA (Santa Cruz sc-4487) was transfected according the manufacturer's recommendations using 10 ml of Oligofectamine (Invitrogen). RNA isolation was performed 48 h after siRNA transfection.
Luciferase assay
The transfected cells were lysed 48 h after transfection and lysates were equalized for protein content as described above. Luciferase assays were performed in 96-well plates using the Luciferase Assay System (Promega, Mannheim, Germany) according to the manufacturer's protocol.
Invasion and motility assays
For invasion assays 80 000 of the indicated cells were plated out in 500 ml SFM in Matrigel-precoated Boyden chambers (Becton Dickinson and Company, Franklin Lakes, NJ, USA). Boyden chambers were placed in 24-well companion plates with DMEM þ 10% fetal calf serum and incubated for 24 h. The media contained the inhibitor PD098059 or SB203580 (both at 10 mM), or dimethylsulfoxide (DMSO) or nothing. The cells were stained with DMEM/MTT solution. Cells remaining in the matrigel were removed using cotton swabs and the membrane with infiltrated cells was cut out. Cotton swabs as well as membranes were placed in DMSO and the solution was densitometrically analyzed at 562 nm against DMSO. The percentage of invasive cells was calculated as percentage optical density of membrane-anchored cells versus overall optical density.
Rescue experiment A total of 80 000 cells (NIHras and MKK3pool) were plated per well in six-well plates and cotransfected with FoxM1 siRNA (8 ml of a 20-mM stock solution) and the FoxM1 cDNA expression plasmid (16 ml of a 20 mM stock solution) after 24 h using 10 ml OligoFectamine (Invitrogen). The FoxM1 expression construct was purchased from Origene (Rockville, MD, USA) (human cDNA, catalog no. SC 112825). Forty-eight hours after transfection the cells were plated out in the invasion chambers and/or harvested for RNA isolation (quantitative PCR (RQ-PCR) analysis).
Colony formation assay A total of 3000 cells were suspended in 1 ml DMEM containing 10% fetal calf serum and 0.35% agar and poured over a 0.7% bottom agar layer in six-well plates. After solidification top agar was covered with 1 ml DMEM supplemented with 10% fetal calf serum. After 4 weeks colonies were stained using MTT vital stain for 5 h according to the standard procedure. Plates were scanned using an Epson scanner.
Anchorage independent growth in petri dishes A total of 300 000 of the indicated cells were plated out on bacterial petri dishes untreated for cell adhesion. Eight hours after seeding, the complete growth medium was exchanged and pictures taken 20 h thereafter.
RNA isolation
Invasion assays were performed as described previously, except that a six-well format was used and 300 000 cells were plated out per chamber. The incubation period was extended to 34 h. Non-invading cells were removed and suspended in RNA lysis buffer (Qiagen Gmbh, Hilden, Germany). Boyden chambers were placed with the membrane's bottom side in RNA lysis buffer and invaded cells were crushed by pressing and turning the membrane in the buffer. RNA isolation for knockdown experiments was performed 48 h after siRNA transfection on NIH3T3 cells in six-well plates using 8ml siRNA of a 20 mM stock solution and 3 ml Oligofectamine (Invitrogen). RNA integrity was assessed by lab-on chip technology, Agilent 2100 bioanalyzer in combination with the RNA 6000 Lab Chip kit, according to the manufacturer's instructions (Agilent Technologies, Boeblingen, Germany). RNA quantity was measured using a NanoDrop TM Spectrophotometer (Thermo Scientific, Waltham, MA, USA).
Genome-wide expression profiling
Genome-wide expression profiling was performed using 'Whole mouse genome 4 Â 44 k oligo microarrays' (Agilent, Santa Clara, CA, USA G4122F). Linear amplification from 500 ng total RNA and spike-in-controls (Agilent no. 5188-5282) was performed using the Agilent 'Low RNA Input Linear Amplification kit Plus, one color' (no. 5188-5339). During this amplification direct labeling of the probe was performed by incorporation of fluorescently labeled nucleotides into the amplified RNA. The labeled probes were purified with 'RNeasy' mini spin columns (Qiagen no. 74104). The Cy3-labeled probe and blocking agent were combined for chemical fragmentation of the probe molecules. Fragmentation was stopped by adding 55ml '2x GEx hybridization buffer HI-RPM' leading to a final volume of 110 ml (Gene Expression Hybridization kit; Agilent no. 5188-5242). Chip hybridization was performed using a gasket/slide-sandwich system and hybridization chamber (Agilent, no. G2534A), according to the manufacturer's instructions. During hybridization slides were rotated at 10 r.p.m. at 65 1C for 16 h. The microarray slides were washed for 1 min in GE Wash Buffer 1 (Agilent, no. 5188-5326) at room temperature, 1 min in GE Wash Buffer 2 (Agilent, no. 5188-5326) at room temperature and 30 s in Acetonitril at room temperature on a magnetic stirrer. The microarray slides were scanned with an Agilent Microarray Scanner and analysis of the resulting array images was performed using the 'Feature Extraction' software (Agilent, version 9.1). Microarray data were stored in the MO-MEX database Bloader that enables direct submission of large batches of MIAME complaint expression profiling data to the ArrayExpress database. Microarray data are available online at ArrayExpress (http://www.ebi.ac.uk/arrayexpress), under accession number E-TABM-561.
Microarray data analysis
Generation of expression matrices, data annotation, filtering and processing as well as network analysis were performed as described in the Supplementary data (previously using TableButler software package; http://www.OncoExpress.org/ software/tablebutler; Domhan, Mol Cancer Ther, 2008, Amir, Proc Natl Acad Sci USA, 2007). All microarray statistic analyses, including t-test with permutation analysis (n ¼ 1000) and cluster analysis, were performed using the SUMO software package (Domhan, Mol Cancer Ther, 2008 , Amir, Proc Natl Acad Sci USA, 2007 , Molecular Cell 2004 . Pathway analysis was performed based on information available on cellular signaling processes (for example, protein-protein interaction, gene ontology, involvement in specific signaling pathway, cellular localization and so on) using a curated database on signaling networks and systems biology package (Metacore s , Genego, St Joseph, MI, USA; www.genego.com). The Metacore manually annotated database was derived from publications on proteins and small molecules (MetaCore, Genego). This was developed with an Oracle, version 9.2.0.4, Standard Edition (Oracle, Redwood Shores, CA, USA)-based architecture for representation of biological functionality and integration of functional, molecular or clinical information. To construct the network, we searched and analyzed direct interactions among the consensus set of Ras-and MKK3-induced genes in invasive NIH3T3 population.
Semi-quantitative endpoint reverse transcription-PCR
A 2-mg of each RNA was used for reverse transcription reaction. Reverse transcription was performed using the HighCapacity cDNA kit (Applied Biosystems, Foster City, CA, USA) according to the instruction manual. The primer sequences can be found in the Supplementary data. (1 ml cDNA was used in the subsequent PCR reaction. The primer sequences for 18sRNA are QPCRRn18SmFor AGAAACG GCTACCACATCCAA, QPCRRn18SmRev CCTGTATTGT TATTTTTCGTCACTACCT; for FoxM1 Mm_Foxm1_1_SG QuantiTect Primer Assay (cat. no. QT00120498; Qiagen) was used. Gel pictures were taken after 30 cycles for FoxM1 and 18S RNA.)
RQ-PCR analysis
Total RNA extraction was performed using the RNAeasy mini kit (Qiagen) followed by cDNA synthesis with the RevertAid M-MuLV transcriptase kit (Fermentas, Burlington, Ontario, Canada). RQ-PCR was performed using a MyiQ SingleColor Real-Time PCR Detection System (Bio-Rad, Munich, Germany) and the Absolute SYBR Green Fluorescein kit (ABgene, Surrey, UK). All of the above were used according to the manufacturers' recommendations. All RQ-PCR experiments were normalized against 18S RNA control.
